{"id":"W4389243107","doi":"10.1182/blood-2023-181886","title":"Influence of Pre-Treatment Features and Therapy Choice By Physicians on Overall Survival in Older Adults with Acute Myeloid Leukemia: A Report from the Beat AML Master Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; Sierra Oncology; MorphoSys; Astellas Pharma; Actuate Therapeutics; Karyopharm Therapeutics; Revolution Medicines; Incyte; Syndax Pharmaceuticals; Oregon Health and Science University; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Agios Pharmaceuticals; Ascentage Pharma; Actinium Pharmaceuticals; Mateon Therapeutics; Jazz Pharmaceuticals; Astex Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Servier; Foghorn Therapeutics; Gilead Sciences; Iterion Therapeutics; Celgene; AstraZeneca; Ono Pharmaceutical; Eli Lilly and Company; Amgen","keywords":"Medicine; Venetoclax; Azacitidine; Internal medicine; Oncology; Myeloid leukemia; Clinical trial; Hematology; Chemotherapy; Leukemia; DNA methylation","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004291985,0.0002153714,0.0005865912,0.0001643656,0.0003109266,0.0008668252,0.0002847244,0.000536154,0.001426858],"category_scores_gemma":[0.01004906,0.0001317909,0.0009551161,0.000474368,0.000262505,0.0005186272,0.0004729565,0.0008247222,0.0001838466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005663338,"about_ca_system_score_gemma":0.0005439164,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001445449,"about_ca_topic_score_gemma":0.002430501,"domain_scores_codex":[0.9981188,0.001037552,0.0001433474,0.0002934132,0.0002762322,0.0001305156],"domain_scores_gemma":[0.9926934,0.003405766,0.002225816,0.0004621361,0.0003871766,0.0008255896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1082128,0.001342623,0.7868615,0.0004501243,0.00307988,0.00007884726,0.0003316471,0.000572622,0.0007588697,0.0002550997,0.003523644,0.09453228],"study_design_scores_gemma":[0.008453411,0.01043801,0.9712754,0.0001351148,0.002821648,0.0001390222,0.0001755234,0.0007099001,0.0003173377,0.0003932348,0.005106207,0.00003505361],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908724,0.004975527,0.0001873466,0.000716094,0.00006249508,0.0000912735,0.001139343,0.000008285836,0.001947264],"genre_scores_gemma":[0.9960272,0.0009575411,0.0002252627,0.0006948407,0.0002204262,0.0001115138,0.001433829,0.000005382258,0.0003239866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004291985,"threshold_uncertainty_score":0.02269846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0131047628027076,"score_gpt":0.2775446329217676,"score_spread":0.2644398701190599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}